Ex-Bristol R&D Chief To Helm Seattle Cancer Center
January 07 2020 - 12:51PM
Dow Jones News
By Melanie Evans
Fred Hutchinson Cancer Research Center named former
Bristol-Myers Squibb Co. executive Thomas Lynch Jr. as its next
president.
Dr. Lynch, who was Bristol's research and development chief,
will take the helm of the nationally-known cancer center on Feb. 1.
He will succeed Gary Gilliland, who announced plans to step down in
September after a four-year run as leader.
The Hutch, as the Seattle-based cancer center is informally
called, is known for its pioneering research into new kinds of
treatments, including cell and gene therapies. It has 200
researchers on staff, which has included three Nobel Prize
laureates.
Dr. Lynch -- a former executive at Massachusetts General
Hospital and the Yale Cancer Center -- has lengthy experience in
cancer-drug research.
He became Bristol's research-and-development chief in 2017, as
the company sought to recover from the unexpected failure of an
important study testing its immunotherapy drug Opdivo in untreated
lung-cancer patients
Dr. Lynch recently left the company after its $74 billion
acquisition of rival Celgene
Write to Melanie Evans at Melanie.Evans@wsj.com
(END) Dow Jones Newswires
January 07, 2020 12:36 ET (17:36 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024
